Monarch Dividend Plus Index ETF (BATS:MDPL – Get Free Report) saw a large decline in short interest during the month of August. As of August 31st, there was short interest totaling 1,023 shares, a decline of 90.2% from the August 15th total of 10,486 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average trading volume of 6,723 shares, the short-interest ratio is presently 0.2 days.
Institutional Inflows and Outflows
A hedge fund recently raised its stake in Monarch Dividend Plus Index ETF stock. Goldman Sachs Group Inc. grew its stake in Monarch Dividend Plus Index ETF (BATS:MDPL – Free Report) by 3.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,922 shares of the company’s stock after acquiring an additional 821 shares during the period. Goldman Sachs Group Inc. owned 1.03% of Monarch Dividend Plus Index ETF worth $588,000 at the end of the most recent reporting period.
Monarch Dividend Plus Index ETF Price Performance
BATS:MDPL opened at $29.37 on Friday. The company has a market cap of $64.03 million, a price-to-earnings ratio of 12.20 and a beta of 0.69. Monarch Dividend Plus Index ETF has a 1 year low of $24.46 and a 1 year high of $31.17. The stock’s 50 day simple moving average is $28.70 and its two-hundred day simple moving average is $26.93.
Monarch Dividend Plus Index ETF Increases Dividend
Monarch Dividend Plus Index ETF Company Profile
The Monarch Dividend Plus Index ETF (MDPL) is an exchange-traded fund that is based on the Monarch Dividend Plus index. MPDL tracks an equal-weighted index of 30 dividend-paying stocks that are expected to provide dividend income and capital appreciation. MDPL was launched on Mar 6, 2024 and is issued by Monarch.
See Also
- Five stocks we like better than Monarch Dividend Plus Index ETF
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for Monarch Dividend Plus Index ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monarch Dividend Plus Index ETF and related companies with MarketBeat.com's FREE daily email newsletter.
